Therapeutic Management of Rare Primary Ovarian Neoplasms: Carcinosarcoma, Leiomyosarcoma, Melanoma and Carcinoid [PDF]
Int J Environ Res Public Health, 2021 Carcinosarcoma, leiomyosarcoma, melanoma and carcinoid as primary tumors in the ovary are extremely rare. In this paper, the authors reviewed the literature from 2010 to 2021, based on specific criteria, to analyze the treatment of these rare ovarian ...
M. Kozłowski +3 more
semanticscholar +2 more sources
Use of tumor markers to distinguish endometriosis-related ovarian neoplasms from ovarian endometrioma [PDF]
Int J Gynecol Cancer, 2020 Objective Only few studies have focused on tumor markers used in the preoperative diagnosis of endometriosis-related ovarian neoplasms, and previous studies have only assessed serum CA125 levels.
Hiroki Shinmura +6 more
semanticscholar +2 more sources
VEGF Expression to Support Targeted Therapy in Ovarian Surface Epithelial Neoplasms [PDF]
Journal of Clinical and Diagnostic Research, 2017 Introduction: Vascular Endothelial Growth Factor (VEGF), a promoter of angiogenesis, is a promising target for antiangiogenic therapy in ovarian cancer.
Sudeshna Mukherjee +7 more
doaj +2 more sources
Aurora-A kinase is differentially expressed in the nucleus and cytoplasm in normal Müllerian epithelium and benign, borderline and malignant serous ovarian neoplasms [PDF]
Diagnostic Pathology, 2021 Background Aurora-A kinase is important for cellular proliferation and is implicated in the tumorigenesis of several malignancies, including of the ovary. Information regarding the expression patterns of Aurora-A in normal Müllerian epithelium as well as
Khaled J. Alkhateeb +9 more
doaj +2 more sources
Ovarian Neoplasms in Children [PDF]
Archives of Disease in Childhood, 1960 Isabella Forshall
+9 more sources
Accuracy of intraoperative frozen section for the evaluation of ovarian neoplasms: an institutional experience [PDF]
World J Surg Oncol, 2016 BackgroundOvarian neoplasms are a heterogeneous group of tumors including surface epithelial, germ cell and sex cord stromal tumors with a subset having low malignant potential (borderline tumors).
A. Hashmi +6 more
semanticscholar +2 more sources
Stromal p16 expression is significantly increased in malignant ovarian neoplasms [PDF]
Oncotarget, 2016 Alterations in p16 protein expression have been reported to be associated with tumor development and progression. However, p16 expression status in the peritumoral stroma has been rarely investigated. We investigated the stromal p16 expression in ovarian
N. Yoon, G. Yoon, C. Park, Hyunsoo Kim
semanticscholar +2 more sources
Pregnancy Outcomes after Conservative Surgery for Early-Stage Ovarian Neoplasms [PDF]
Asian Pac J Cancer Prev, 2017 Objective: This retrospective, single institute study aimed to evaluate pregnancy and oncologic outcomes in reproductive-age Thai women with early-stage ovarian neoplasms undergoing conservative surgical treatment. Methods: Medical records of 84 women of
Panwad Ratanasrithong, M. Benjapibal
semanticscholar +2 more sources
Diffusion weighted imaging for the differential diagnosis of benign vs. malignant ovarian neoplasms. [PDF]
Oncol Lett, 2016 In order to assess the diagnostic accuracy of diffusion weighted imaging (DWI) in differentiating between benign and malignant ovarian neoplasms, a systemic meta-analysis was conducted. Relevant studies were retrieved from scientific literature databases,
Xiangfu Meng +4 more
semanticscholar +2 more sources
Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms [PDF]
Oncotarget, 2016 Kras mutation is a common phenomenon in many human neoplasms. We aimed to assess the Kras mutational status along the histological continuum from normal ovaries to the development of benign, borderline and malignant ovarian mucinous neoplasms.
Yi-Ju Lee +7 more
semanticscholar +2 more sources